Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNS60 in ACL Reconstruction
NCT01922427Phase 2Withdrawn
- Sponsor
- Revalesio Corporation
- Primary completion
- Oct 2014
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
01
Overview
A Phase 2 trial of RNS60 in postoperative pain, sponsored by Revalesio Corporation. Status: withdrawn.
02
Drugs
RNS60
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01922427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922427.